NLS Pharmaceutics Ltd. Warrant (NLSPW) EPS by Year
NLSPW
NLS Pharmaceutics Ltd. Warrant earned $2.16 per diluted share in fiscal year 2025. This represents a decrease of 11.1% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters NLS Pharmaceutics Ltd. Warrant has filed alongside them.
FY2025 annual
EPS (Diluted)$2.16
YoY-11.1%
Source SEC Filings (10-K/10-Q)Latest period FY2025, ended Dec 31, 2025ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
NLSPW EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was NLS Pharmaceutics Ltd. Warrant's diluted earnings per share in fiscal year 2025?
NLS Pharmaceutics Ltd. Warrant earned $2.16 per diluted share in fiscal year 2025.
How fast is NLS Pharmaceutics Ltd. Warrant's diluted earnings per share growing?
NLS Pharmaceutics Ltd. Warrant (NLSPW) diluted earnings per share fell by 11.1% year over year, from $2.43 to $2.16 in fiscal year 2025.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what NLS Pharmaceutics Ltd. Warrant (NLSPW) reported on that line in every period on record.
